Conditional deletion of the retinoblastoma (Rb) gene in ovarian granulosa cells leads to premature ovarian failure

Molecular Endocrinology

Volumn 22, Issue 9, 2008, Pages 2141-2161

  Andreu Vieyra, Claudia ^a   Chen, Ruihong ^a   Matzuk, Martin M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CRE RECOMBINASE; CYCLIN E; FOLLITROPIN; FOLLITROPIN RECEPTOR BINDING INHIBITOR; FORKHEAD TRANSCRIPTION FACTOR; GONADOTROPIN; LIVER RECEPTOR HOMOLOG 1; MUELLERIAN INHIBITING FACTOR; MYC PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN FOS; PROTEIN P130; RETINOBLASTOMA PROTEIN; STEM CELL FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; GENE DELETION; GRANULOSA CELL; HORMONE BLOOD LEVEL; MOUSE; NONHUMAN; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE DEVELOPMENT; OVARY TUMOR; OVULATION; PATHOGENESIS; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; BASE SEQUENCE; DNA PRIMERS; ESTRUS; FEMALE; FOLLICULAR ATRESIA; GENE DELETION; GENE EXPRESSION REGULATION; GENES, RETINOBLASTOMA; GRANULOSA CELLS; HORMONES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; OVARIAN FAILURE, PREMATURE; OVARIAN NEOPLASMS; OVARY; OVULATION;

EID: 50649095353     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0033     Document Type: Article

References (112)

1. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A 1999 The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501-534
2. Classon M, Harlow E 2002 The retinoblastoma tumour suppressor in development and cancer. Nat Rev 2:910-917
3. Nevins JR 2001 The Rb/E2F pathway and cancer. Hum Mol Genet 10:699-703
4. Harbour JW, Dean DC 2000 The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14:2393-2409
5. Elledge SJ, Winston J, Harper JW 1996 A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis. Trends Cell Biol 6:388-392
6. Delston RB, Harbour JW 2006 Rb at the interface between cell cycle and apoptotic decisions. Curr Mol Med 6:713-718
7. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T 1996 Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10:1633-1644
8. Nguyen DX, McCance DJ 2005 Role of the retinoblastoma tumor suppressor protein in cellular differentiation. J Cell Biochem 94:870-879
9. Wikenheiser-Brokamp KA 2006 Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell Mol Life Sci 63:767-780
10. Grossel MJ, Hinds PW 2006 Beyond the cell cycle: a new role for Cdk6 in differentiation. J Cell Biochem 97:485-493
11. Korenjak M, Brehm A 2005 E2F-Rb complexes regulating transcription of genes important for differentiation and development. Curr Opin Genet Dev 15:520-527
12. Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB, Kaelin Jr WG 1998 Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev 12:95-106
13. Matzuk MM 2000 Revelations of ovarian follicle biology from gene knockout mice. Mol Cell Endocrinol 163:61-66
14. Pangas SA 2007 Growth factors in ovarian development. Semin Reprod Med 25:225-234
15. Uhlenhaut NH, Treier M 2006 Foxl2 function in ovarian development. Mol Genet Metab 88:225-234
16. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP 2003 Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 211:85-90
17. Rolaki A, Drakakis P, Millingos S, Loutradis D, Makrigiannakis A 2005 Novel trends in follicular development, atresia and corpus luteum regression: a role for apoptosis. Reprod Biomed Online 11:93-103
18. Robker RL, Richards JS 1998 Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol 12:924-940
19. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT, Elledge SJ, Weinberg RA 1996 Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 384:470-474
20. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A 1996 Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732
21. Jirawatnotai S, Moons DS, Stocco CO, Franks R, Hales DB, Gibori G, Kiyokawa H 2003 The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 cooperate to restrict proliferative life span in differentiating ovarian cells. J Biol Chem 278:17021-17027
22. Ogawa T, Yogo K, Ishida N, Takeya T 2003 Synergistic effects of activin and FSH on hyperphosphorylation of Rb and G1/S transition in rat primary granulosa cells. Mol Cell Endocrinol 210:31-38
23. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A 1992 α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-319
24. Burns KH, Agno JE, Sicinski P, Matzuk MM 2003 Cyclin D2 and p27 are tissue-specific regulators of tumorigenesis in inhibin α knockout mice. Mol Endocrinol 17:2053-2069
25. Cipriano SC, Chen L, Burns KH, Koff A, Matzuk MM 2001 Inhibin and p27 interact to regulate gonadal tumorigenesis. Mol Endocrinol 15:985-996
26. Scambia G, Lovergine S, Masciullo V 2006 RB family members as predictive and prognostic factors in human cancer. Oncogene 25:5302-5308
27. Lazzerini Denchi E, Helin K 2005 E2F1 is crucial for E2F-dependent apoptosis. EMBO Rep 6:661-668
28. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA 1992 Effects of an Rb mutation in the mouse. Nature 359:295-300
29. Andreu-Vieyra C, Chen R, Matzuk MM 2007 Effects of granulosa cell-specific deletion of Rb in Inha-α null female mice. Endocrinology 148:3837-3849
30. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR 2003 Genetic studies of the AMH/MIS signaling pathway for Mullerian duct regression. Mol Cell Endocrinol 211:15-19
31. Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM 2004 Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 18:953-967
32. Pangas SA, Li X, Robertson EJ, Matzuk MM 2006 Premature luteinization and cumulus cell defects in ovarian-specific Smad4 knockout mice. Mol Endocrinol 20:1406-1422
33. Pangas SA, Jorgez CJ, Tran M, Agno J, Li X, Brown CW, Kumar TR, Matzuk MM 2007 Intraovarian activins are required for female fertility. Mol Endocrinol 21:2458-2471
34. Pangas SA, Li X, Umans L, Zwijsen A, Huylebroeck D, Gutierrez C, Wang D, Martin JF, Jamin SP, Behringer RR, Robertson EJ, Matzuk MM 2008 Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 28:248-257
35. Abel MH, Huhtaniemi I, Pakarinen P, Kumar TR, Charlton HM 2003 Age-related uterine and ovarian hypertrophy in FSH receptor knockout and FSHβ subunit knockout mice. Reproduction 125:165-173
36. O'Shaughnessy PJ, McLelland D, McBride MW 1997 Regulation of luteinizing hormone-receptor and follicle-stimulating hormone-receptor messenger ribonucleic acid levels during development in the neonatal mouse ovary. Biol Reprod 57:602-608
37. Thomas FH, Vanderhyden BC 2006 Oocyte-granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth. Reprod Biol Endocrinol 4:19
38. Skinner MK 2005 Regulation of primordial follicle assembly and development. Human Reprod Update 11:461-471
39. Ismail RS, Okawara Y, Fryer JN, Vanderhyden BC 1996 Hormonal regulation of the ligand for c-kit in the rat ovary and its effects on spontaneous oocyte meiotic maturation. Mol Reprod Dev 43:458-469
40. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, Grootegoed JA 1995 Anti-Mullerian hormone and anti-Mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136:4951-4962
41. Visser JA, Themmen AP 2005 Anti-Mullerian hormone and folliculogenesis. Mol Cell Endocrinol 234:81-86
42. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP 1999 Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140:5789-5796
43. Visser JA, Durlinger AL, Peters IJ, van den Heuvel ER, Rose UM, Kramer P, de Jong FH, Themmen AP 2007 Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Mullerian hormone null mice. Endocrinology 148:2301-2308
44. Zhu L 2005 Tumour suppressor retinoblastoma protein Rb: a transcriptional regulator. Eur J Cancer 41:2415-2427
45. Classon M, Dyson N 2001 p107 and p130: versatile proteins with interesting pockets. Exp Cell Res 264:135-147
46. Robbins PD, Horowitz JM, Mulligan RC 1990 Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 346:668-671
47. Moses HL, Yang EY, Pietenpol JA 1990 TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247
48. Kim SJ, Lee HD, Robbins PD, Busam K, Sporn MB, Roberts AB 1991 Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc Natl Acad Sci USA 88:3052-3056
49. Ghiglieri C, Khatchadourian C, Tabone E, Hendrick JC, Benahmed M, Menezo Y 1995 Immunolocalization of transforming growth factor-β1 and transforming growth factor-β2 in the mouse ovary during gonadotrophin-induced follicular maturation. Hum Reprod 10:2115-2119
50. Gueripel X, Benahmed M, Gougeon A 2004 Sequential gonadotropin treatment of immature mice leads to amplification of transforming growth factor β action, via upregulation of receptor-type 1, Smad 2 and 4, and downregulation of Smad 6. Biol Reprod 70:640-648
51. Dunkel L, Tilly JL, Shikone T, Nishimori K, Hsueh AJ 1994 Follicle-stimulating hormone receptor expression in the rat ovary: increases during prepubertal development and regulation by the opposing actions of transforming growth factors β and α. Biol Reprod 50:940-948
52. Inoue K, Nakamura K, Abe K, Hirakawa T, Tsuchiya M, Oomori Y, Matsuda H, Miyamoto K, Minegishi T 2003 Mechanisms of action of transforming growth factor β on the expression of follicle-stimulating hormone receptor messenger ribonucleic acid levels in rat granulosa cells. Biol Reprod 69:1238-1244
53. Piontkewitz Y, Sundfeldt K, Hedin L 1997 The expression of c-myc during follicular growth and luteal formation in the rat ovary in vivo. J Endocrinol 152:395-406
54. Delidow BC, White BA, Peluso JJ 1990 Gonadotropin induction of c-fos and c-myc expression and deoxyribonucleic acid synthesis in rat granulosa cells. Endocrinology 126:2302-2306
55. Ness JM, Kasson BG 1992 Gonadotropin regulation of c-fos and c-jun messenger ribonucleic acids in cultured rat granulosa cells. Mol Cell Endocrinol 90:17-25
56. Sharma SC, Richards JS 2000 Regulation of AP1 (Jun/ Fos) factor expression and activation in ovarian granulosa cells. Relation of JunD and Fra2 to terminal differentiation. J Biol Chem 275:33718-33728
57. Popov B, Chang LS, Serikov V 2005 Cell cycle-related transformation of the E2F4-p130 repressor complex. Biochem Biophys Res Commun 336:762-769
58. Thompson TB, Cook RW, Chapman SC, Jardetzky TS, Woodruff TK 2004 βA versus βB: is it merely a matter of expression? Mol Cell Endocrinol 225:9-17
59. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM 1999 Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 13:1018-1034
60. Mendelson CR, Kamat A 2007 Mechanisms in the regulation of aromatase in developing ovary and placenta. J Steroid Biochem Mol Biol 106:62-70
61. Boerboom D, Pilon N, Behdjani R, Silversides DW, Sirois J 2000 Expression and regulation of transcripts encoding two members of the NR5A nuclear receptor subfamily of orphan nuclear receptors, steroidogenic factor-1 and NR5A2, in equine ovarian cells during the ovulatory process. Endocrinology 141:4647-4656
62. Falender AE, Lanz R, Malenfant D, Belanger L, Richards JS 2003 Differential expression of steroidogenic factor-1 and FTF/LRH-1 in the rodent ovary. Endocrinology 144:3598-3610
63. Weck J, Mayo KE 2006 Switching of NR5A proteins associated with the inhibin β-subunit gene promoter after activation of the gene in granulosa cells. Mol Endocrinol 20:1090-1103
64. Yu FQ, Han CS, Yang W, Jin X, Hu ZY, Liu YX 2005 Activation of the p38 MAPK pathway by follicle-stimulating hormone regulates steroidogenesis in granulosa cells differentially. J Endocrinol 186:85-96
65. Rey R, Lukas-Croisier C, Lasala C, Bedecarras P 2003 AMH/MIS: what we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 211:21-31
66. Arango NA, Lovell-Badge R, Behringer RR 1999 Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell 99:409-419
67. Moumne L, Batista F, Benayoun BA, Nallathambi J, Fellous M, Sundaresan P, Veitia RA 2008 The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol 282:2-11
68. Pisarska MD, Bae J, Klein C, Hsueh AJ 2004 Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 145:3424-3433
69. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC, Treier M 2004 The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131:933-942
70. Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, Kimber W, Forabosco A, Cao A, Schlessinger D, Pilia G 2004 Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13:1171-1181
71. Ottolenghi C, Omari S, Garcia-Ortiz JE, Uda M, Crisponi L, Forabosco A, Pilia G, Schlessinger D 2005 Foxl2 is required for commitment to ovary differentiation. Hum Mol Genet 14:2053-2062
72. Batista F, Vaiman D, Dausset J, Fellous M, Veitia RA 2007 Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics. Proc Natl Acad Sci USA 104:3330-3335
73. Pannetier M, Fabre S, Batista F, Kocer A, Renault L, Jolivet G, Mandon-Pepin B, Cotinot C, Veitia R, Pailhoux E 2006 FOXL2 activates P450 aromatase gene transcription: towards a better characterization of the early steps of mammalian ovarian development. J Mol Endocrinol 36:399-413
74. Findlay JK, Drummond AE 1999 Regulation of the FSH receptor in the ovary. Trends Endocrinol Metab 10:183-188
75. Heckert LL, Griswold MD 2002 The expression of the follicle-stimulating hormone receptor in spermatogenesis. Recent Prog Horm Res 57:129-148
76. Kim SJ, Wagner S, Liu F, O'Reilly MA, Robbins PD, Green MR 1992 Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2. Nature 358:331-334
77. Nilsson E, Rogers N, Skinner MK 2007 Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction 134:209-221
78. Heckert LL 2001 Activation of the rat follicle-stimulating hormone receptor promoter by steroidogenic factor 1 is blocked by protein kinase A and requires upstream stimulatory factor binding to a proximal E box element. Mol Endocrinol 15:704-715
79. Hermann BP, Heckert LL 2007 Transcriptional regulation of the FSH receptor: new perspectives. Mol Cell Endocrinol 260-262:100-108
80. Levallet J, Koskimies P, Rahman N, Huhtaniemi I 2001 The promoter of murine follicle-stimulating hormone receptor: functional characterization and regulation by transcription factor steroidogenic factor 1. Mol Endocrinol 15:80-92
81. Fayard E, Auwerx J, Schoonjans K 2004 LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol 14:250-260
82. Hutt KJ, McLaughlin EA, Holland MK 2006 Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis. Mol Human Reprod 12:61-69
83. Driancourt MA, Reynaud K, Cortvrindt R, Smitz J 2000 Roles of KIT and KIT LIGAND in ovarian function. Rev Reprod 5:143-152
84. Shen WH, Moore CC, Ikeda Y, Parker KL, Ingraham HA 1994 Nuclear receptor steroidogenic factor 1 regulates the mullerian inhibiting substance gene: a link to the sex determination cascade. Cell 77:651-661
85. Woodson KG, Crawford PA, Sadovsky Y, Milbrandt J 1997 Characterization of the promoter of SF-1, an orphan nuclear receptor required for adrenal and gonadal development. Mol Endocrinol 11:117-126
86. Udvadia AJ, Rogers KT, Higgins PD, Murata Y, Martin KH, Humphrey PA, Horowitz JM 1993 Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc Natl Acad Sci USA 90:3265-3269
87. Banchio C, Lingrell S, Vance DE 2007 Sp-1 binds promoter elements that are regulated by retinoblastoma and regulate CTP:phosphocholine cytidylyltransferase-α transcription. J Biol Chem 282:14827-14835
88. Udvadia AJ, Templeton DJ, Horowitz JM 1995 Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci USA 92:3953-3957
89. Noe V, Alemany C, Chasin LA, Ciudad CJ 1998 Retinoblastoma protein associates with SP1 and activates the hamster dihydrofolate reductase promoter. Oncogene 16:1931-1938
90. Gray SA, Mannan MA, O'Shaughnessy PJ 1995 Development of cytochrome P450 aromatase mRNA levels and enzyme activity in ovaries of normal and hypogonadal (hpg) mice. J Mol Endocrinol 14:295-301
91. Carreau S, Bourguiba S, Lambard S, Silandre D, Delalande C 2004 The promoter (s) of the aromatase gene in male testicular cells. Reprod Biol 4:23-34
92. Pezzi V, Sirianni R, Chimento A, Maggiolini M, Bourguiba S, Delalande C, Carreau S, Ando S, Simpson ER, Clyne CD 2004 Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression. Endocrinology 145:2186-2196
93. Yamaguchi T, Yamaguchi S, Hirai T, Kitano T 2007 Follicle-stimulating hormone signaling and Foxl2 are involved in transcriptional regulation of aromatase gene during gonadal sex differentiation in Japanese flounder, Paralichthys olivaceus. Biochem Biophys Res Commun 359:935-940
94. Lalli E, Sassone-Corsi P 2003 DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol 17:1445-1453
95. Iyer AK, McCabe ER 2004 Molecular mechanisms of DAX1 action. Mol Genet Metab 83:60-73
96. Saxena D, Escamilla-Hernandez R, Little-Ihrig L, Zeleznik AJ 2007 Liver receptor homolog-1 and steroidogenic factor-1 have similar actions on rat granulosa cell steroidogenesis. Endocrinology 148:726-734
97. Suzuki T, Kasahara M, Yoshioka H, Umesono K, Morohashi K 2002 LXXLL motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Endocr Res 28:537
98. Kim J, Prawitt D, Bardeesy N, Torban E, Vicaner C, Goodyer P, Zabel B, Pelletier J 1999 The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation. Mol Cell Biol 19:2289-2299
99. Matsumura I, Tanaka H, Kanakura Y 2003 E2F1 and c-Myc in cell growth and death. Cell Cycle 2:333-338
100. Nasi S, Ciarapica R, Jucker R, Rosati J, Soucek L 2001 Making decisions through Myc. FEBS Lett 490:153-162
101. Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Li W, Bertino JR, Wahl GM 1995 Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 92:5436-5440
102. Eppig JJ, Downs SM 1984 Chemical signals that regulate mammalian oocyte maturation. Biol Reprod 30:1-11
103. Maddison LA, Sutherland BW, Barrios RJ, Greenberg NM 2004 Conditional deletion of Rb causes early stage prostate cancer. Cancer Res 64:6018-6025
104. Vooijs M, van der Valk M, te Riele H, Berns A 1998 Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse. Oncogene 17:1-12
105. Mantela J, Jiang Z, Ylikoski J, Fritzsch B, Zacksenhaus E, Pirvola U 2005 The retinoblastoma gene pathway regulates the postmitotic state of hair cells of the mouse inner ear. Development 132:2377-2388
106. -/- mice are normal in vivo but exhibit proliferation and pigmentation defects in vitro. Pigment Cell Res 18:252-264
107. Skapek SX, Pan YR, Lee EY 2006 Regulation of cell lineage specification by the retinoblastoma tumor suppressor. Oncogene 25:5268-5276
108. Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q 2005 Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 102:16090-16095
109. Marino S, Vooijs M, van Der Gulden H, Jonkers J, Berns A 2000 Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev 14:994-1004
110. Pedersen T, Peters H 1968 Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil 17:555-557
111. Varani S, Elvin JA, Yan C, DeMayo J, DeMayo FJ, Horton HF, Byrne MC, Matzuk MM 2002 Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol Endocrinol 16:1154-1167
112. Cowell IG, Aucott R, Mahadevaiah SK, Burgoyne PS, Huskisson N, Bongiorni S, Prantera G, Fanti L, Pimpinelli S, Wu R, Gilbert DM, Shi W, Fundele R, Morrison H, Jeppesen P, Singh PB 2002 Heterochromatin, HP1 and methylation at lysine 9 of histone H3 in animals. Chromosoma 111:22-36